One of the most common supportive care challenges faced by the chronic lymphocytic leukemia patient is infectious complications. The increased r...... more

During the summer, many hospitals were faced with an erythromycin eye ointment shortage. When trying to find a replacement product, many were ...... more

Oseltamivir is an orally available neuraminidase inhibitor that has antiviral activity against influenza A and influenza B viruses. It is FDA...... more

With an increasing incidence of resistant gram-positive pathogens such as methicillin-resistant Staphylococcus aureus, conventional antib...... more

There has been an intensified focus on the emergence of methicillin-resistant Staphlococcus aureus, both community-acquired and hospit...... more

The recent economic recession has left many of us striving to improve our fiscal fitness and incorporate less expensive options into all aspects...... more

Vancomycin is likely the most well-known, most-studied antibiotic. It has become a core part of an empiric antimicrobial regimen in inpatient ...... more

Aminoglycoside antibiotics are implicated as among the most nephrotoxic drugs available. During the past two decades, practitioners had all but ...... more

Candidemia has proven it is an important emerging nosocomial infection. Its prevalence in hospital settings has become alarming and should be ...... more

Novel influenza A (H1N1) is a new influenza virus of swine origin and was first described in April of 2009. This virus is a genetic hybrid of ...... more